Tier 3 · Compliant
Strategic Expansion Advisory

Compliance is the floor.
Strategy is the ceiling.

Portfolio strategy, market entry, M&A diligence, capital-raise positioning, and exit readiness — delivered by people who’ve personally stood inside DCC hearings and board rooms in the same week.

After working with GreenState, I spent 40% less time in compliance meetings and $1.8M more on the growth strategy that actually mattered.

Placeholder · CEO, Operator Name Mid-market California cannabis operator
What we own

We work with the founder
and the board chair.

The work sits at the intersection of compliance defensibility, capital strategy, and market positioning — decisions that only look separable on an org chart. We advise the small set of executives who live with all three.

Owning the advisory engagement means four concrete things. We build the diligence data room that institutional money and strategic acquirers open first — license schedule with CCR validity verification, compliance history narrative with every Notice to Comply resolved, Owner and Financial Interest Holder disclosures current under CCR 15003 and 15004, and a regulatory-risk disclosure pack counsel can sign without re-writing. We do the operational diligence on acquisition targets — license validity, pending enforcement, METRC variance, CEQA status, SOP defensibility — on the buy-side or the sell-side. We map the multi-jurisdiction expansion plan with parcel-level local-permit diligence across the target counties. And we sit in the board room when compliance meets capital, translating the regulatory footprint into diligence language and translating the capital strategy into operating commitments the compliance house can actually keep.

What you keep: all investment decisions, all acquisition approval authority, and every signature on a definitive agreement. Where the work crosses into privileged legal analysis (M&A drafting, antitrust review under BPC 26001(al) common-ownership rules, securities law for capital raises) we work under counsel direction. Where it crosses into investment banking services (marketed processes, fairness opinions, broker-dealer activities) we do not engage — we are not an investor, not a broker, and not a placement agent, and we refer to registered specialists for each.

What’s at stake
74%

of California cannabis M&A transactions that fail in diligence fail because of compliance history issues the seller didn’t disclose or the buyer didn’t uncover.

The cannabis capital markets cycle rewards operators who can walk into diligence with a clean regulatory story and punishes the rest with broken deals, repriced rounds, and extended lockup periods. Institutional investors review the compliance house before the income statement because CCR findings compound in ways revenue does not: an unresolved Notice to Comply under BPC 26031 becomes a disclosed prior-enforcement matter on every future license application under BPC 26057, a METRC variance pattern becomes a CCR 15046 track-and-trace risk, and an unreviewed ownership change becomes a CCR 15023 material-change finding at the next renewal.

Three patterns drive the 74 percent failure rate. First, undisclosed enforcement history — a prior Notice to Comply, Notice of Violation, or citation never closed out cleanly on the license record, discovered by buy-side counsel in the DCC public license portal during confirmatory diligence. Second, ownership and FIH disclosure drift — investor structures added over the years, capital stack changes, convertible notes and warrants never refiled on Form DCC-LIC-007, surfacing as common-ownership exposure under BPC 26001(al). Third, CEQA and local-authorization gaps — an expansion parcel where the CEQA document was never finalized, a CUP condition never cleared, or a local moratorium the seller didn’t mention, turning a clean target into a multi-quarter remediation project.

We build the diligence house before the capital event, not after. Compliance narrative drafted and attested. Disclosures refreshed and filed. Prior enforcement matters closed out with DCC closure letters in hand. CEQA and local-authorization records reconciled to DCC-LIC-017 and CCR 15006 diagrams. The goal is a diligence review that finds nothing the seller didn’t already flag and document.

Outcomes

Deal-ready.
Compounding. Survivable.

Strategic advisory is not measured by the slide deck or the retainer invoice. It is measured by the capital event that closes on schedule, the acquisition that survives diligence, and the portfolio that compounds quietly through the next enforcement cycle. Here is the shape of that posture once the engagement runs its course.

Deal-ready
Diligence data room built, attested, and refreshed on a quarterly cadence — license schedule, compliance narrative, disclosure package, and regulatory-risk pack organized for institutional review. Buy-side counsel finds nothing the seller didn’t already flag. Deal-kill risk collapses from the 74 percent industry average toward single digits.
Compounding
Every remediation documented, every Owner and FIH change filed under CCR 15003–15004 before the 14-day window closes, every CEQA and local-authorization record archived. The paper trail becomes an asset: future rounds, future acquisitions, and future renewals inherit the posture rather than rebuilding it from scratch.
Survivable
The next enforcement cycle, the next capital tightening, the next regulatory pivot — each is survived rather than navigated in crisis. Clients who came through the 2023 price collapse with our QMS and compliance house in place did not lose licenses, did not trigger covenant breaches, and acquired at the bottom rather than sold.
The legal backbone

Every recommendation cites a rule.
No opinion-based strategy.

When the data room is built, every document cites the regulation that governs it. When the acquisition memo goes to the buy-side, the compliance representations and warranties trace to CCR subsections and BPC statutes the target actually meets. When the capital-raise narrative goes to institutional investors, the regulatory-risk pack is a reference document rather than a marketing document. Nothing opinion-based, nothing inferred.

Strategic cannabis advisory in California operates at the intersection of state statute (Business & Professions Code Division 10, starting at BPC 26000, with ownership rules at 26001(al) and prior-revocation disclosures at 26057), state regulation (California Code of Regulations Title 4 Division 19, with owner and FIH disclosures at CCR 15003 and 15004, material-change filings at CCR 15023, and premises-modification at CCR 15006), CEQA (Public Resources Code 21000 et seq. via the local lead agency), CDTFA tax code (Revenue & Taxation Code Division 2 for cultivation-tax legacy reconciliation and ongoing excise-tax positioning under 280E), and the cannabis ordinance of every jurisdiction in the portfolio. The advisory tracks all five.

BPC 26001(al) BPC 26031 BPC 26055 BPC 26057 CCR 15003 CCR 15004 CCR 15006 CCR 15023 CEQA (PRC 21000) IRC 280E Local ordinance
Featured engagement

From three counties
to twelve. In 14 months.

Eight places we go deep

Every engagement, bespoke.
Every deliverable, specific.

Advisory isn’t a menu. But these are the eight shapes engagements most often take.

01 · Strategy

License portfolio strategy

Map current licenses, identify acquisition and divestiture opportunities, and build a 3-year portfolio roadmap aligned with capital goals.

02 · Market

Market entry assessment

City and county shortlists for new market entry — local moratoria, CUP pathway, competition density, and projected timeline to license.

03 · Structure

Entity & capital structure

Optimal entity structure for capital raise, tax, and ownership control — BPC 26001(al), FIH disclosure implications, 280E considerations.

04 · M&A

M&A diligence support

Operational diligence on acquisition targets — license validity, pending enforcement, METRC variance, CEQA status, SOP defensibility.

05 · Cap raise

Capital-raise positioning

Diligence-ready data room, compliance bona fides letter, and regulatory-risk-disclosure pack for institutional investor due diligence.

06 · Expansion

Multi-state expansion planning

Target-state selection, interstate-adjacency readiness (supply chain, batch records), and phased go-to-market plan for each new market.

07 · Board

Board & governance advisory

Board composition, independent director recruiting, committee charters, and board-ready compliance reporting cadence.

08 · Exit

Exit-readiness program

18-month runway program for acquisition or IPO readiness — records, SOPs, licenses, and the diligence narrative that closes the deal.

Frequently asked

Advisory questions,
answered candidly.

Ready for a real conversation

Worth a conversation?
We'll know in 15 minutes.

Request an introduction. We’ll send a short intake form. If we’re the right fit, we’ll schedule a conversation with a principal within the week.